2022
Rheumatic Disorders
Alexander S, Duddy C, Danve A, Sehra S. Rheumatic Disorders. 2022, 557-566. DOI: 10.1007/978-3-030-92042-5_55.ChaptersNoninflammatory causesJoint painMuscle painRheumatoid arthritisInflammatory bowel diseaseInflammatory causesInflammatory arthritidesPsoriatic arthritisReactive arthritisBowel diseaseCommon presentationRheumatic disordersLaboratory presentationCommon causeArthritisPainMultiple specialtiesCausePresentationArthritidesFibromyalgiaSpondylitisOsteoarthritisGoutDisease
2020
Managing rheumatic diseases during COVID-19
Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clinical Rheumatology 2020, 39: 3245-3254. PMID: 32895747, PMCID: PMC7476772, DOI: 10.1007/s10067-020-05387-8.Peer-Reviewed Original ResearchConceptsAutoimmune rheumatic diseasesRheumatic diseasesImmunosuppressive agentsRheumatology practiceCOVID-19Multisystem autoimmune rheumatic diseaseLong-term complicationsCOVID-19 patientsCoronavirus disease 2019 (COVID-19) pandemicCOVID-19 infectionDisease 2019 pandemicMode of spreadImmunosuppressant managementImmunosuppressant medicationsViral illnessOrgan failureClinical featuresAutoimmune diseasesSerious infectionsTreatment optionsEffective vaccineImmune systemMedicationsDiseasePatients
2018
Intravenous Immunoglobulin for Mixed Connective Tissue Disease Presenting With Bilateral Trigeminal Neuropathy
Danve A, Zabad R, Erickson A. Intravenous Immunoglobulin for Mixed Connective Tissue Disease Presenting With Bilateral Trigeminal Neuropathy. American Journal Of Therapeutics 2018, 25: e383-e385. PMID: 28079540, DOI: 10.1097/mjt.0000000000000553.Peer-Reviewed Original Research
2017
Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
Danve AS, Kulkarni S. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus? American Journal Of Therapeutics 2017, 24: e347-e350. PMID: 26103543, DOI: 10.1097/mjt.0000000000000297.Peer-Reviewed Original ResearchConceptsRheumatoid arthritisGlycemic controlTNF inhibitorsInsulin resistanceInsulin sensitivityTumor necrosis factor inhibitorsTumor necrosis factor alphaConcomitant rheumatoid arthritisInflammatory rheumatic diseasesNecrosis factor inhibitorsNecrosis factor alphaIncident diabetesDiabetes mellitusRheumatic diseasesFactor inhibitorsProinflammatory cytokinesFactor alphaPatientsMellitusArthritisInhibitorsDiabetesInflammationCytokinesDiseaseComorbidities in Spondyloarthritis
Danve A, Raychaudhuri S. Comorbidities in Spondyloarthritis. Current Treatment Options In Rheumatology 2017, 3: 63-74. DOI: 10.1007/s40674-017-0061-3.Peer-Reviewed Original ResearchHealth care costsCertain comorbiditiesCommon comorbiditiesGastroduodenal ulcersSpA patientsComorbid conditionsSleep apneaVertebral fracturesLung diseaseMyocardial infarctionInflammatory diseasesCardiovascular diseaseComprehensive carePeripheral skeletonCare costsHealth outcomesComorbiditiesDiseasePatientsHypertensionApneaRheumatologistsSpondyloarthritisInfarctionUlcers
2015
The ongoing quest for biomarkers in Ankylosing Spondylitis
Danve A, O'Dell J. The ongoing quest for biomarkers in Ankylosing Spondylitis. International Journal Of Rheumatic Diseases 2015, 18: 826-834. PMID: 26469363, DOI: 10.1111/1756-185x.12779.Peer-Reviewed Original ResearchConceptsRadiographic progressionC-reactive proteinChronic inflammatory diseaseQuality of lifeDisease activityPotential clinical applicationsHLA-B27Ankylosing SpondylitisDiscovery of biomarkersInflammatory diseasesEarly diagnosisNew biomarkersSpondylitisBiomarkersDisease assessmentClinical applicationProgressionImmunopathogenesisTherapySymptomsDiseaseDiagnosis